Daisy Robinton, PhD

Co-Founder & CEO, Oviva Therapeutics

Dr. Daisy Robinton is passionate about elevating women’s health and challenging the status quo of female aging. She launched Oviva Therapeutics with the vision to tackle aging in women while addressing the historic gender disparity in biomedical research and healthcare.  Dr. Robinton completed her PhD in Human Biology and Translational Medicine at Harvard University and landed on the Forbes 30 Under 30 list for her scientific discoveries. Her writing has been published in periodicals such as Nature, Vanity Fair and NEO.LIFE. Her work as a molecular biologist, writer, public speaker, and lifestyle & fitness model, contribute to the unique lens with which she examines the intersection of science and culture.